Researchers at EMBL-EBI in Cambridge and the German Cancer Research Center (DKFZ) have introduced Delphi-2M, a generative transformer trained on health records that estimates individual disease risks [...]
Merck is using AI agents to cut drug discovery cycles by a third and ship compliant marketing materials up to 80% faster — but VP of Digital Platforms Sean Finnerty says the only reason it's wo [...]